The 471delAAAG mutation and C353T polymorphism in the RNASEL gene in sporadic and inherited cancer in Israel

Familial Cancer

Volumn 5, Issue 4, 2006, Pages 389-395

  Dagan, Efrat ^a,b   Laitman, Yael ^c,d   Levanon, Nurit ^a   Feuer, Avner ^c   Sidi, Ami A ^e   Baniel, Jack ^f,g   Korach, Yaacov ^d   Baruch, Gilad Ben ^d   Friedman, Eitan ^c,g   Gershoni Baruch, Ruth ^a,h  

^a RAMBAM MEDICAL CENTER   (Israel)

^b UNIVERSITY OF HAIFA   (Israel)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e WOLFSON MEDICAL CENTER   (Israel)

^f RABIN MEDICAL CENTER   (Israel)

^g TEL AVIV UNIVERSITY   (Israel)

^h TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Breast ovarian cancer; DGGE; DHPLC; Founder mutation; Inherited predisposition; Prostate cancer; RNASEL gene

Indexed keywords

ADENINE; BRCA1 PROTEIN; BRCA2 PROTEIN; GUANINE; VALINE;

ADULT; AGE DISTRIBUTION; AGED; AMPLICON; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; FOUNDER EFFECT; GENE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; ISRAEL; JEW; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION MAPPING; RNASEL GENE; SEQUENCE ANALYSIS;

BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDORIBONUCLEASES; FEMALE; GENE DELETION; GENES, BRCA1; GENES, BRCA2; HUMANS; MALE; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 33845515081     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-006-0010-z     Document Type: Article

References (21)

1. Damber L, Gronberg H, Damber JE (1998) Familial prostate cancer and possible associated malignancies: nation-wide register cohort study in Sweden. Int J Cancer 78:293-297
2. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89:3367-3371
3. Carpten J, Nupponen N, Isaacs S, et al (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30:181-184
4. Smith JR, Freije D, Carpten JD, et al (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genomewide search. Science 274:1371-1374
5. Sood R, Bonner TI, Makalowska I, et al (2001) Cloning and characterization of 13 novel transcript and the human rgs8 gene from the 1q25 region encompassing the hereditary prostate cancer (hpc1) locus. Genomics 73:211-222
6. Silverman RH (2003) Implications for RNase L in prostate cancer biology. Biochemistry 42:1805-1812
7. Maier C, Haeusler J, Herkommer K, et al (2005) Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. Br J Cancer 92:1159-1164
8. Rokman A, Ikonen T, Seppala EH, et al (2002) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 70:1299-1304
9. Rennert H, Bercovich D, Hubert A, et al (2002) A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet 71:981-984
10. Kotar K, Hamel N, Thiffault I, Foulkes WD (2003) The RNASEL 471delAAAG allele and prostate cancer in Ashkenazi Jewish men. J Med Genet 40:e22
11. Israeli O, Gotlieb WH, Friedman E, et al (2004) Genomic analyses of primary and metastatic serous epithelial ovarian cancer. Cancer Genet Cytogenet 154:16-21
12. American Society of Clinical Oncology Policy Statement Update (2003) Genetic Testing for Cancer Susceptibility. JCO 21:2397-2406
13. Abeliovich D, Kaduri L, Lerer I, et al (1997) The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60:505-514
14. Rohlfs EM, Learning WG, Friedman KJ, et al (1997) Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis. Clin Chem 43:24-29
15. Casey G, Neville PJ, Plummer SJ, et al (2002) RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 32:581-583
16. Bruchim Bar-Sade R, Kruglikova A, Modan B, et al (1998) The 185delAG BRCA1 mutation originated before the dispersion of Jews in the Diaspora and is not limited to Ashkenazim. Hum Mol Genet 7:801-805
17. Patael Y, Figer A, Gershoni-Baruch R, et al (1999) Common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi Jews. Eur J Hum Genet 7:555-559
18. Wang L, McDonnell SK, Elkins DA, et al (2002) Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 71:116-123
19. Nakazato H, Suzuki K, Matsui H, et al (2003) Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population. Br J Cancer 89:691-696
20. Wiklund F, Jonsson BA, Brookes AJ, et al (2004) Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res 10:7150-7156
21. Sevinc A, Yannoukakos D, Konstantopoulou I, et al (2004) Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer. Anticancer Res 24:1547-1549